INVO Fertility, Inc.(IVF)Earnings, Financials & Key RatiosINVO Fertility, Inc. (IVF) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's net margin of -340.92% and persistent reliance on dilutive financing indicate a high risk of further value destruction for equity holders.
INVO Fertility, Inc. (IVF) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
INVO Fertility, Inc. (IVF) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q3 2026Latest | Jun 22, 2026 | $3.38vs $2.75-22.9% | $2Mvs $2M+0.0% |
| Q4 2025 | Nov 17, 2025 | $6.16vs $11.52+46.5% | $2Mvs $2M-3.2% |
| Q3 2025 | Aug 14, 2025 | $63.60vs $14.40-341.7% | $2Mvs $2M-1.1% |
| Q2 2025 | May 20, 2025 | $300.75vs $14.40-1988.5% | $2Mvs $2M+1.9% |
Recent stock market news and headlines for INVO Fertility, Inc. (IVF)
INVO Fertility Inc (NASDAQ:IVF) shares are surging Friday afternoon following a pair of key operational and regulatory milestones disclosed in a new SEC Form 8-K filing. Here's what investors need to know.
23% revenue growth, elimination of all Series C-2 Preferred Stock and warrant liabilities, and a strengthened balance sheet
Key metrics vs top competitors for INVO Fertility, Inc. (IVF)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $1.99 | $3.26M | -0.03 | 4.73% | -340.92% | -233.56% | — | |
| $272.31 | $39B | -179.15 | 35.9% | -9.05% | -15.13% | — | |
| $28.86 | $2.26B | 44.40 | 10.4% | 5.23% | 13.34% | — | |
| $14.74 | $933.91M | 10.31 | -6.16% | 23.27% | 13.28% | — | |
| $14.03 | $5.35B | -3.80 | 38.2% | -234.83% | -51.65% | — | |
| $76.01 | $16.97B | 30.53 | 1.74% | 13.18% | 11.01% | — |
INVO Fertility, Inc. (IVF) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
INVO Fertility, Inc. (IVF) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jun 2, 2026·SEC
Jun 2, 2026·SEC
Apr 29, 2026·SEC
Get notified when IVF posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
INVO Fertility, Inc. (IVF) stock FAQ — growth, dividends, profitability & financials explained
INVO Fertility, Inc. (IVF) reported $7.2M in revenue for fiscal year 2025.
INVO Fertility, Inc. (IVF) grew revenue by 4.7% over the past year. Growth has been modest.
INVO Fertility, Inc. (IVF) reported a net loss of $11.5M for fiscal year 2025.
INVO Fertility, Inc. (IVF) has a return on equity (ROE) of -233.6%. Negative ROE indicates the company is unprofitable.
INVO Fertility, Inc. (IVF) had negative free cash flow of $5.4M in fiscal year 2025, likely due to heavy capital investments.
